ZOCCHI, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 506
EU - Europa 463
AS - Asia 175
AF - Africa 1
Totale 1.145
Nazione #
US - Stati Uniti d'America 505
PL - Polonia 126
IE - Irlanda 95
IT - Italia 80
SE - Svezia 73
HK - Hong Kong 60
RU - Federazione Russa 53
CN - Cina 48
JO - Giordania 32
SG - Singapore 17
CH - Svizzera 13
KR - Corea 11
DE - Germania 7
GB - Regno Unito 6
IN - India 4
FI - Finlandia 3
UA - Ucraina 3
NL - Olanda 2
VN - Vietnam 2
BE - Belgio 1
CA - Canada 1
ES - Italia 1
MU - Mauritius 1
TR - Turchia 1
Totale 1.145
Città #
Warsaw 126
Dublin 95
Chandler 73
Fairfield 54
Hong Kong 44
Ashburn 38
Seattle 25
Altamura 24
Florence 24
Lawrence 24
Houston 19
Cambridge 18
Princeton 18
Wilmington 18
Woodbridge 18
Buffalo 17
Moscow 16
New York 16
Beijing 14
Bern 13
Boston 13
Shanghai 13
San Diego 11
Seoul 11
Singapore 11
Ann Arbor 7
Medford 7
Hillsboro 6
Kent 5
Los Angeles 5
West Jordan 4
Boardman 3
Redwood City 3
Andover 2
Campi Bisenzio 2
Cesano Boscone 2
Effeltrich 2
Guangzhou 2
Helsinki 2
Jinan 2
Kilburn 2
Lodi 2
Lusciano 2
Munich 2
Norwalk 2
Pune 2
Reggio Emilia 2
Trinitapoli 2
Tukwila 2
Vellore 2
Arezzo 1
Breendonk 1
Falls Church 1
Grosseto 1
Hagen 1
Hangzhou 1
Hoofddorp 1
Leawood 1
Lecce 1
London 1
Milan 1
Monmouth Junction 1
Nanjing 1
Naples 1
Pisa 1
Pontedera 1
Prato 1
Redmond 1
Salerno 1
Southwark 1
Staranzano 1
Toronto 1
Turin 1
Viagrande 1
Washington 1
Totale 852
Nome #
Clinical events beyond one year after an acute coronary syndrome: Insights from the RECLOSE 2-ACS study 224
Risk stratification using the CHA2DS2-VASc score in Takotsubo syndrome: Data from the Takotsubo Italian network 78
Relation between post-myocardial infarct remodelling and gelatinase activity in patients enrolled in the TIPTOP trial 65
Emerging Medical Treatment for Hypertrophic Cardiomyopathy 57
Strength of clinical indication and therapeutic impact of the implantable cardioverter defibrillator in patients with hypertrophic cardiomyopathy 56
Decrease and Delay in Hospitalization for Acute Coronary Syndromes During the 2020 SARS-CoV-2 Pandemic 55
Predicting Mortality Risk in Older Hospitalized Persons With COVID-19: A Comparison of the COVID-19 Mortality Risk Score with Frailty and Disability 48
Prevalence of Inherited Cardiac Diseases Among Young Patients Requiring Permanent Pacing 47
Changes in the perceived epidemiology of amyloidosis: 20 year-experience from a Tertiary Referral Centre in Tuscany 45
Discriminatory ability of CHA2DS2-VASc score to predict residual platelet reactivity and outcomes in patients with acute coronary syndrome 44
Factors associated with persistence of symptoms 1 year after COVID-19: A longitudinal, prospective phone-based interview follow-up cohort study 43
Cellular determinants of arrhythmic rysk in hypertrophic cardiomyopathy 43
Impact of mitraclip intervention on left ventricular remodelling and clinical outcome: data from Florence registry 42
Early Diagnosis and Outcome in Patients With Wild-Type Transthyretin Cardiac Amyloidosis 41
Incidence of light chain amyloidosis in Florence metropolitan area, Italy: a population-based study 38
Relationship between hyponatremia at hospital admission and cardiopulmonary profile at follow-up in patients with SARS-CoV-2 (COVID-19) infection 34
Prevalence and prognostic role of nonsustained ventricular tachycardia in cardiac amyloidosis 32
Clinical course and outcome of pregnancy in patients with hypertrophic cardiomyopathy 32
Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoring 24
Prevalence and predictors of bradyarrhythmias requiring permanent pacing in patients with Anderson-Fabry disease 23
Sex-related differences in clinical presentation and all-cause mortality in patients with cardiac transthyretin amyloidosis and light chain amyloidosis 22
Myocardial infarction with non-obstructive coronary arteries in hypertrophic cardiomyopathy vs Fabry disease 21
Safety and efficacy of ranolazine in hypertrophic cardiomyopathy: Real-world experience in a National Referral Center 18
Clinical scenarios of HCM-related mortality: Relevance of age and stage of disease at presentation 18
Impact of Pregnancy on the Natural History of Women with Hypertrophic Cardiomyopathy 14
Clinical staging of Anderson-Fabry cardiomyopathy: An operative proposal 13
Totale 1.177
Categoria #
all - tutte 6.487
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.487


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202093 0 10 5 5 10 8 12 12 13 5 10 3
2020/202174 2 8 0 12 11 7 2 4 12 5 7 4
2021/2022141 10 2 7 1 2 7 0 13 19 9 28 43
2022/2023432 32 79 22 15 22 71 60 33 56 7 15 20
2023/2024249 6 24 26 12 17 36 15 56 6 19 23 9
2024/202570 41 29 0 0 0 0 0 0 0 0 0 0
Totale 1.177